We would like to update our customers amid the ever-changing COVID-19 virus outbreak. To play our part in stopping the virus in its tracks, we have decided to temporarily close the main HistologiX Ltd. Lab from 25th March until further notice in line with the UK Government guidance and our business continuity plans.
We feel this is the right thing to do to safeguard the health and wellbeing of our staff and contribute towards the massive effort to combat the COVID-19 virus outbreak.
Please be reassured that our staff will still be able to support digital image analysis and will be working as normal to complete study paperwork. However, we will be unable to start new studies, continue with on-going wet lab work or accept samples to our facility.
We would like to take this opportunity to thank you for your continued business and support.
We will be in touch with Clients individually to discuss their specific projects and will update all our customers when the Lab reopens as normal.
In the meantime, please take care of yourselves and your families and we look forward to continuing to support your drug research and development when it is right to do so.
If you have any questions please contact your business development representative or email email@example.com.
Morag McFarlane, CEO, The Intelligent Tissue Group
Andrew Lawrence, Laboratory Director, HistologiX Ltd.